Factors associated with failure to complete adjuvant chemotherapy in pancreatic cancer-Reference-Cited by-同舟云学术

Factors associated with failure to complete adjuvant chemotherapy in pancreatic cancer

Published:2016-04 Issue:4 Volume:211 Page:787-792
ISSN:0002-9610
Container-title:The American Journal of Surgery
language:en
Short-container-title:The American Journal of Surgery

Author:

Akahori Takahiro,Sho Masayuki,Tanaka Toshihiro,Kinoshita Shoichi,Nagai Minako,Nishiwada Satoshi,Nishiofuku Hideyuki,Ohbayashi Chiho,Kichikawa Kimihiko,Nakajima Yoshiyuki

Funder

Nara Medical University

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference30 articles.

1. Pancreatic cancer;Li;Lancet,2004

2. Pancreatic cancer: surgery alone is not sufficient;Traverso;Surg Endosc,2006

3. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?;Schnelldorfer;Ann Surg,2008

4. Pancreatic adenocarcinoma: the actual 5-year survivors;Ferrone;J Gastrointest Surg,2008

5. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial;Oettle;JAMA,2007

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Pre-operative Geriatric Nutritional Risk Index With Complete Adjuvant Chemotherapy and Prognosis Post-pancreatectomy;Anticancer Research;2023-12-30

2. Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients;BioScience Trends;2023-08-31

3. Identification of Nectin Family Interactive Gene Panel and Stratification of Clinical Outcomes in Patients with Pancreatic Cancer;Journal of the American College of Surgeons;2023-07-28

4. Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer;Nutrients;2022-12-06

5. Preoperative cachexia index can predict the prognosis of extrahepatic biliary tract cancer after resection;Surgical Oncology;2022-09